One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
High-intensity theatre (HIT) lists to tackle the elective surgery backlog
Marc A. Furrer, Imran Ahmad, Jonathan Noel, Kariem El-Boghdadly & Ben ChallacombeÂ
doi : 10.1038/s41585-023-00775-6
Volume 20 Issue 8, August 2023
A new role for the Y chromosome in cancer growth and immunotherapy response
Annette FennerÂÂ
Metabolic alterations drive enzalutamide resistance
Maria Chiara MasoneÂÂ
Choice of fluid affects DGF in transplant recipients
Maria Chiara MasoneÂ
PARP inhibitors plus enzalutamide to treat mCRPC
Maria Chiara MasoneÂÂ
BAUS23 � shining a spotlight on important issues
Louise StoneÂÂ
Serum tumour markers for testicular cancer recurrence
Matthew J. Murray, Cinzia G. Scarpini & Nicholas ColemanÂ
Human in vitro spermatogenesis as a regenerative therapy � where do we stand?
Meghan Robinson, Sydney Sparanese, Luke Witherspoon & Ryan FlanniganÂ
Preclinical models of prostate cancer � modelling androgen dependency and castration resistance in vitro, ex vivo and in vivo
Lucas Germain, Camille Lafront, Virginie Paquette, Bertrand Neveu, Jean-Sébastien Paquette, Frédéric Pouliot & Étienne Audet-WalshÂ
Unanswered questions in prostate cancer � findings of an international multi-stakeholder consensus by the PIONEER consortium
Muhammad Imran Omar, Steven MacLennan, Maria J. Ribal, Monique J. Roobol, Konstantinos Dimitropoulos, Thomas van den Broeck, Sara J. MacLennan, Susan Evans Axelsson, Giorgio Gandaglia, Peter-Paul Willemse, Ken Mastris, John Butler Ransohoff, Zsuzsanna Devecseri, Thomas Abbott, Bertrand De Meulder, Anders Bjartell, Alex Asiimwe, James N’Dow & The PIONEER Consortium
Treatment de-escalation for stage II seminoma
Georgina E. Wood, Florence Chamberlain, Ben Tran, Ciara Conduit, Elizabeth Liow, David L. Nicol, Jonathan Shamash, Constantine Alifrangis & Prabhakar RajanÂ
